Retinitis: Clinical Trials

90 trials for Retinitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

72 completed, 7 unknown, 4 recruiting, 3 active not recruiting. 27 Not applicable, 18 Phase 2, 13 Phase 3, 10 Phase 1, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable27Completed 23, Unknown 3, Recruiting 1
Phase 218Completed 16, Active not recruiting 1, Withdrawn 1
Phase 313Completed 11, Unknown 2
Phase 110Completed 7, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 43Completed 3
Early Phase 11Recruiting 1

Follow Retinitis: new trials by email Literature Review of Retinitis trials Research Report on Retinitis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
LB-DTK-CMV - CMV Retinitis
Not applicableRecruitingLucasBio52026-04-272026-07-01
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Anterior Uveitis (AU), Birdshot Chorioretinitis
RecruitingOregon Health and Science University1252024-09-012025-07-17
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
Gene Therapy product-MCO-010 - Retinitis Pigmentosa, Retinitis
Active not recruitingNanoscope Therapeutics Inc.182023-12-082025-03-24
Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis
2% Ganciclovir Eye Drops - Cytomegalovirus Retinitis, Ganciclovir Eye Drops
Early Phase 1RecruitingTianjin Medical University152023-07-012023-06-23
Pregnancy and Congenital Toxoplasmosis
Estimation of the occurrence of retinochoroiditis in women with congenital toxoplasmosis and previous retinochoroiditis lesions (recurrence) during pregnancy and postpartum. - Congenital Toxoplasmosis, Retinochoroiditis
CompletedHospices Civils de Lyon762023-05-102026-01-22
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Companion blood samples with procedure - Autoimmune Diseases, Ulcerative Colitis
CompletedTScan Therapeutics, Inc.2382023-01-032026-09-15
Ocular Changes in Vitiligo Patients on Therapy
Optical coherence tomography angiography (OCT-A) - Vitiligo, Chorioretinopathy
UnknownBenha University1002022-03-102022-04-19
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
Gene Therapy Product-MCO-010, Sham Injection - Retinitis Pigmentosa, Retinitis
Phase 2CompletedNanoscope Therapeutics Inc.272021-07-132024-03-22
Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis
Cytomegalovirus Retinitis
CompletedKuifang Du502021-04-012021-07-21
Natural History Study of Retinitis Pigmentosa Type 11
Clinical examinations - Retinitis Pigmentosa 11, Retinitis Pigmentosa
Active not recruitingOslo University Hospital302021-02-012025-03-21
SD-OCT Guided Treatment of Fungal Chorioretinitis
Fluconazole 150 mg - Fungal Retinitis
UnknownBenha University102020-01-152021-12-15
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
QR-1123, Sham procedure - Autosomal Dominant Retinitis Pigmentosa, Eye Diseases
Phase 1 / Phase 2Active not recruitingProQR Therapeutics112019-10-072022-05-06
Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis
Intravitreal injection, Fluorescent angiography, Visometry - Chorioretinitis
Not applicableUnknownThe Filatov Institute of Eye Diseases and Tissue Therapy1002018-03-272021-02-03
Exercise and RP (AVAMC and Emory)
Spin exercise - Retinitis Pigmentosa
Not applicableCompletedEmory University42018-02-232018-12-26
Prophylactic Laser Photocoagulation and Vitrectomy for Acute Retinal Necrosis
Acute Retinal Necrosis, Retinal Detachment
CompletedNational Taiwan University Hospital232014-08-012018-04-26
Ocular Manifestations in Rheumatic Diseases
No intervention used - Uveitis, Conjunctivitis
CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's50002013-05-012022-04-12
The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients
pars plana vitrectomy - Acute Retinal Necrosis
CompletedChongqing Medical University302012-04-012017-08-24
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Trimethoprim-Sulfamethoxazole - Ocular Toxoplasmosis
Phase 3CompletedUniversity of Campinas, Brazil1412011-10-012016-07-12
Postnatal HCMV Infection in Very Preterm Infants. Implications, Morbidity, Growth and Neurodevelopmental Outcomes.
Hearing Loss, Mental Retardation
WithdrawnOslo University Hospital2010-08-012022-09-23

Showing 20 of 90. Sign in to see all of them.

Narrower conditions

Cytomegalovirus Retinitis (64)  ·  HIV Infections (58)  ·  Acquired Immunodeficiency Syndrome (48)  ·  Cytomegalovirus Infections (33)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (30)  ·  AIDS-Related Opportunistic Infections (26)  ·  Chorioretinitis (9)  ·  Retinitis Pigmentosa (6)  ·  Birdshot Chorioretinopathy (5)  ·  Retinal Diseases (5)  ·  Eye Diseases (4)  ·  Eye Diseases, Hereditary (4)  ·  Uveitis (4)  ·  Behcet Syndrome (3)

Broader conditions

Eye Diseases (86)  ·  Retinal Diseases (85)  ·  Infections (70)  ·  Immune System Diseases (68)  ·  Virus Diseases (67)  ·  DNA Virus Infections (66)  ·  Eye Infections (66)  ·  Herpesviridae Infections (66)  ·  Eye Infections, Viral (64)  ·  Urogenital Diseases (64)  ·  Genital Diseases (63)  ·  RNA Virus Infections (63)  ·  Blood-Borne Infections (62)  ·  Communicable Diseases (62)  ·  Immunologic Deficiency Syndromes (62)

Interventions

Ganciclovir (27)  ·  Foscarnet (13)  ·  Cidofovir (10)  ·  Probenecid (5)  ·  fomivirsen (4)  ·  sevirumab (4)  ·  Valganciclovir (3)  ·  Zidovudine (3)  ·  sargramostim (2)  ·  Acyclovir (1)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)  ·  Antibodies, Monoclonal (1)  ·  Bosentan (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (22)  ·  Hoffmann-La Roche (9)  ·  Johns Hopkins Bloomberg School of Public Health (6)  ·  Astra USA (4)  ·  Ionis Pharmaceuticals, Inc. (4)  ·  National Eye Institute (NEI) (4)  ·  Gilead Sciences (3)  ·  Roche Global Development (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Benha University (2)  ·  Nanoscope Therapeutics Inc. (2)  ·  Oslo University Hospital (2)  ·  Agouron Pharmaceuticals (1)  ·  American National Red Cross (1)  ·  Chiron Corporation (1)

Countries

United States (61)  ·  Canada (6)  ·  France (4)  ·  Puerto Rico (3)  ·  United Kingdom (3)  ·  China (2)  ·  Germany (2)  ·  Iran (2)  ·  Norway (2)  ·  Austria (1)  ·  Brazil (1)  ·  Egypt (1)  ·  Hungary (1)  ·  Israel (1)  ·  Singapore (1)

Top investigators

Douglas Jabs, MD (2)  ·  Hardy WD (2)  ·  MA Jacobson (2)  ·  Amal A Yousif, MD (1)  ·  Andrii MD Korol, PhD (1)  ·  Behrouz Nikbin, MD (1)  ·  Borucki M (1)  ·  Brosgart C (1)  ·  C Crumpacker (1)  ·  CA Benson (1)  ·  CS Crumpacker (1)  ·  Chang-Ping Lin, MD (1)  ·  Chao Chen (1)

Results publications

PMID 31042791, PMID 11919489, PMID 12095806, PMID 12232843, PMID 12559647, PMID 15079763, PMID 15498605, PMID 16192248, PMID 20926833, PMID 22562517, PMID 23773637, PMID 24150759, PMID 24614374, PMID 24949994, PMID 25219982, PMID 25298411, PMID 25638011, PMID 25812924, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 28878616, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 30816625, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32343050, PMID 32497307, PMID 33029806, PMID 33903114, PMID 34302290, PMID 35370711, PMID 35491971, PMID 37204866, PMID 39250617, PMID 40010761, PMID 41247430, PMID 9400786

NIH funding

U10EY008057 (3), R21EY036563 (1), U01AI027668 (1)